Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Merck (MRK)

Add to Watchlists
Create an Alert
57.50 -0.27  -0.47% NYSE Apr 23, 4:59PM BATS Real time Currency in USD

Merck Research and Development Expense (Quarterly):

1.835B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Merck Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Merck Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 1.835B
Sept. 30, 2013 1.66B
June 30, 2013 2.101B
March 31, 2013 1.907B
Dec. 31, 2012 2.224B
Sept. 30, 2012 1.918B
June 30, 2012 2.165B
March 31, 2012 1.862B
Dec. 31, 2011 2.419B
Sept. 30, 2011 1.954B
June 30, 2011 1.936B
March 31, 2011 2.158B
Dec. 31, 2010 4.559B
Sept. 30, 2010 2.322B
June 30, 2010 2.179B
March 31, 2010 2.051B
Dec. 31, 2009 1.972B
Sept. 30, 2009 1.254B
June 30, 2009 1.395B
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

MRK Research and Development Expense (Quarterly) Benchmarks

Companies
Bristol-Myers Squibb 957.00M
AbbVie 846.00M
Johnson & Johnson 1.831B

MRK Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.254B Sep 2009
Maximum 4.559B Dec 2010
Average 2.098B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.